Current research on respiratory viral infections: Fourth International Symposium

[1]  R. Kanner,et al.  Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. , 2015, The American review of respiratory disease.

[2]  A. García-Sastre,et al.  Rescue of influenza A virus from recombinant DNA. , 2007, Journal of virology.

[3]  S. Elankumaran,et al.  Recombinant Newcastle disease virus as a vaccine vector. , 2003, Poultry science.

[4]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[5]  S. Johnston,et al.  Respiratory viruses: do they protect from or induce asthma? , 2002, Allergy.

[6]  P. Openshaw,et al.  Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood , 2002, The Journal of experimental medicine.

[7]  O. Ruuskanen,et al.  Metapneumovirus and acute wheezing in children , 2002, The Lancet.

[8]  L. Anderson,et al.  Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. , 2002, The Journal of infectious diseases.

[9]  S. Chanock,et al.  A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. , 2002, The Journal of infectious diseases.

[10]  J. Taubenberger,et al.  Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Boivin,et al.  Respiratory Tract Reinfections by the New Human Metapneumovirus in an Immunocompromised Child , 2002, Emerging infectious diseases.

[12]  S. Bonini,et al.  Hay fever and asthma in relation to markers of infection in the United States. , 2002, The Journal of allergy and clinical immunology.

[13]  R. Webster,et al.  Lethal H5N1 influenza viruses escape host anti-viral cytokine responses , 2002, Nature Medicine.

[14]  C. Metcalfe,et al.  Enhanced IL‐4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy , 2002, European Respiratory Journal.

[15]  J. Patrie,et al.  Combined Antiviral-Antimediator Treatment for the Common Cold , 2002, The Journal of infectious diseases.

[16]  S. Wenzel,et al.  Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. , 2002, The American journal of medicine.

[17]  L. Anderson,et al.  Characterization of Human Metapneumoviruses Isolated from Patients in North America , 2002, The Journal of infectious diseases.

[18]  D. Fleming,et al.  Human Metapneumovirus as a Cause of Community-Acquired Respiratory Illness , 2002, Emerging infectious diseases.

[19]  J. Wilschut,et al.  Virosome-mediated delivery of protein antigens to dendritic cells. , 2002, Vaccine.

[20]  N. Papadopoulos,et al.  Association of rhinovirus infection with increased disease severity in acute bronchiolitis. , 2002, American journal of respiratory and critical care medicine.

[21]  A. Monto,et al.  Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. , 2002, Antiviral research.

[22]  Y. Li,et al.  IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Carole A Bewley,et al.  Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants. , 2002, Journal of molecular biology.

[24]  N. Papadopoulos,et al.  A defective type 1 response to rhinovirus in atopic asthma , 2002, Thorax.

[25]  M. Howe.  Australian find suggests worldwide reach for metapneumovirus , 2002, The Lancet Infectious Diseases.

[26]  A. Osterhaus,et al.  Analysis of the genomic sequence of a human metapneumovirus. , 2002, Virology.

[27]  Stephen T Holgate,et al.  Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study , 2002, The Lancet.

[28]  A. Osterhaus,et al.  Sequence Variation in a Newly Identified HLA-B35-Restricted Epitope in the Influenza A Virus Nucleoprotein Associated with Escape from Cytotoxic T Lymphocytes , 2002, Journal of Virology.

[29]  G. Gray,et al.  Large epidemic of respiratory illness due to adenovirus types 7 and 3 in healthy young adults. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  L. Anderson,et al.  Molecular Epidemiology of Adenovirus Type 7 in the United States, 1966–2000 , 2002, Emerging infectious diseases.

[31]  R. Webster,et al.  Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA. , 2002, The Journal of infectious diseases.

[32]  S. Johnston,et al.  Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects. , 2002, The Journal of infectious diseases.

[33]  P. Patterson,et al.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness , 2002, Current Opinion in Neurobiology.

[34]  S. Blomqvist,et al.  Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. , 2002, The Journal of general virology.

[35]  S. Withers,et al.  Evidence of human metapneumovirus in Australian children , 2002, The Medical journal of Australia.

[36]  M. St. Claire,et al.  Mucosal Immunization of Rhesus Monkeys against Respiratory Syncytial Virus Subgroups A and B and Human Parainfluenza Virus Type 3 by Using a Live cDNA-Derived Vaccine Based on a Host Range-Attenuated Bovine Parainfluenza Virus Type 3 Vector Backbone , 2002, Journal of Virology.

[37]  P. Gibson,et al.  Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.

[38]  J. Wilschut,et al.  VIROSOMES IN VACCINE DEVELOPMENT: INDUCTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY WITH VIROSOME-ENCAPSULATED PROTEIN ANTIGENS , 2002, Journal of liposome research.

[39]  J. Bonnefoy,et al.  Differential Histopathology and Chemokine Gene Expression in Lung Tissues following Respiratory Syncytial Virus (RSV) Challenge of Formalin-Inactivated RSV- or BBG2Na-Immunized Mice , 2001, Journal of Virology.

[40]  S. P. Kachur,et al.  Malaria surveillance--United States, 1998. , 2001, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[41]  A. Osterhaus,et al.  Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults. , 2001, The Journal of infectious diseases.

[42]  F. Ahmed,et al.  Influenza Vaccination for Healthy Young Adults , 2001 .

[43]  L. Anderson,et al.  Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus , 2001, Journal of Virology.

[44]  B. Murphy,et al.  A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys , 2001, Journal of Virology.

[45]  J. Gwaltney,et al.  Variant Effect of First- and Second-Generation Antihistamines as Clues to Their Mechanism of Action on the Sneeze Reflex in the Common Cold , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  S. Fatemi,et al.  Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia , 2001, Neuroreport.

[47]  S. Fatemi,et al.  Altered levels of Reelin and its isoforms in schizophrenia and mood disorders , 2001, Neuroreport.

[48]  D. Fleming,et al.  Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study , 2001, The Lancet.

[49]  T. Gentle,et al.  Respiratory virus infections in adult T cell-depleted transplant recipients: the role of cellular immunity. , 2001, Transplantation.

[50]  R. Glueck.  Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization. , 2001, Vaccine.

[51]  Y. Guan,et al.  Cocirculation of Avian H9N2 and Contemporary “Human” H3N2 Influenza A Viruses in Pigs in Southeastern China: Potential for Genetic Reassortment? , 2001, Journal of Virology.

[52]  P. Openshaw,et al.  Immunopathogenesis of vaccine-enhanced RSV disease. , 2001, Vaccine.

[53]  R. Webster,et al.  Infection with H9N2 influenza viruses confers immunity against lethal H5N1 infection , 2001 .

[54]  P. Openshaw,et al.  Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology , 2001, European journal of immunology.

[55]  N. Russell,et al.  Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation , 2001, Bone Marrow Transplantation.

[56]  Lihan K. Yan,et al.  Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. , 2001, Pediatrics.

[57]  M. Boeckh,et al.  Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. , 2001, Blood.

[58]  S. Crawford,et al.  Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. , 2001, The Journal of infectious diseases.

[59]  D. Kontoyiannis,et al.  Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins , 2001, Bone Marrow Transplantation.

[60]  S. Kehl,et al.  Two fatal cases of adenovirus-related illness in previously healthy young adults--Illinois, 2000. , 2001, MMWR. Morbidity and mortality weekly report.

[61]  S. Holgate,et al.  Rhinovirus infection up‐regulates eotaxin and eotaxin‐2 expression in bronchial epithelial cells , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[62]  M. Zambon,et al.  Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza , 2001, The Lancet.

[63]  T. Kuiken,et al.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease , 2001, Nature Medicine.

[64]  S. Blomqvist,et al.  Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age , 2001, The Pediatric infectious disease journal.

[65]  R. Chanock,et al.  Current research on respiratory viral infections: Third International Symposium , 2001, Antiviral Research.

[66]  K G Moons,et al.  Clinical signs and symptoms predicting influenza infection. , 2001, Archives of internal medicine.

[67]  S. Fatemi,et al.  Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly , 2001, Molecular Psychiatry.

[68]  J. Gutiérrez-Ramos,et al.  Inhibition of T1/St2 during Respiratory Syncytial Virus Infection Prevents T Helper Cell Type 2 (Th2)- but Not Th1-Driven Immunopathology , 2001, The Journal of experimental medicine.

[69]  K. Nichol,et al.  Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. , 2001, Archives of internal medicine.

[70]  F. Hayden,et al.  Position statement: global neuraminidase inhibitor susceptibility network. , 2001, Antiviral research.

[71]  M. Lawrence,et al.  The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. , 2001, Structure.

[72]  Roderick C. Jones,et al.  Outbreak of adenovirus genome type 7d2 infection in a pediatric chronic-care facility and tertiary-care hospital. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  David E. Swayne,et al.  Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[74]  B. Niggemann,et al.  Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study , 2001, BMJ : British Medical Journal.

[75]  F. Hayden,et al.  Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. , 2001, The Journal of infectious diseases.

[76]  J. Oxford,et al.  Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. , 2001, JAMA.

[77]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[78]  P. Ward,et al.  Oral oseltamivir treatment of influenza in children , 2001, The Pediatric infectious disease journal.

[79]  B. Winther,et al.  Computed Tomography Imaging of the Maxillary and Ethmoid Sinuses in Children with Short-duration Purulent Rhinorrhea , 2001, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[80]  Gerhard Walzl,et al.  Mucosal Delivery of a Respiratory Syncytial Virus CTL Peptide with Enterotoxin-Based Adjuvants Elicits Protective, Immunopathogenic, and Immunoregulatory Antiviral CD8+ T Cell Responses1 , 2001, The Journal of Immunology.

[81]  R. Dobson.  “Health weather forecasts” to be piloted in England , 2001, BMJ : British Medical Journal.

[82]  A. Berger.  Drug delivery system may combat cancer , 2001, BMJ : British Medical Journal.

[83]  M. Horwitz,et al.  Adenovirus immunoregulatory genes and their cellular targets. , 2001, Virology.

[84]  P. Schipper,et al.  Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR , 2001, Journal of Clinical Microbiology.

[85]  Jen-Ren Wang,et al.  Respiratory Viral Infections among Pediatric Inpatients and Outpatients in Taiwan from 1997 to 1999 , 2001, Journal of Clinical Microbiology.

[86]  P S Kim,et al.  Structural characterization of the human respiratory syncytial virus fusion protein core. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[87]  T. Heikkinen.  The role of respiratory viruses in otitis media. , 2000, Vaccine.

[88]  I. Brown,et al.  H9N2 subtype influenza A viruses in poultry in pakistan are closely related to the H9N2 viruses responsible for human infection in Hong Kong. , 2000, Virology.

[89]  G. Boivin,et al.  Predicting influenza infections during epidemics with use of a clinical case definition. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  S. Fatemi,et al.  Hippocampal CA4 Reelin-positive neurons , 2000, Molecular Psychiatry.

[91]  R. Karron,et al.  Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. , 2000, The Journal of infectious diseases.

[92]  A. Monto,et al.  Effect of zanamivir on duration and resolution of influenza symptoms. , 2000, Clinical therapeutics.

[93]  T. Powers,et al.  Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group. , 2000, The Pediatric infectious disease journal.

[94]  Y. Guan,et al.  H9N2 Influenza Viruses Possessing H5N1-Like Internal Genomes Continue To Circulate in Poultry in Southeastern China , 2000, Journal of Virology.

[95]  M. Meltzer,et al.  Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. , 2000, JAMA.

[96]  J. McAuliffe,et al.  Bovine Parainfluenza Virus Type 3 (BPIV3) Fusion and Hemagglutinin-Neuraminidase Glycoproteins Make an Important Contribution to the Restricted Replication of BPIV3 in Primates , 2000, Journal of Virology.

[97]  B. Murphy,et al.  Recombinant Respiratory Syncytial Virus That Does Not Express the NS1 or M2-2 Protein Is Highly Attenuated and Immunogenic in Chimpanzees , 2000, Journal of Virology.

[98]  P. Christie,et al.  Rapid virological surveillance of community influenza infection in general practice , 2000, BMJ : British Medical Journal.

[99]  K. Conzelmann,et al.  Bovine Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Cooperatively Antagonize Alpha/Beta Interferon-Induced Antiviral Response , 2000, Journal of Virology.

[100]  Daniel R Weinberger,et al.  To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test , 2000, Neuropsychopharmacology.

[101]  G. Gray,et al.  Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[102]  W. Samsonoff,et al.  Isolation and characterization of adenovirus 5 from the brain of an infant with fatal cerebral edema. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[103]  J. Castro‐Rodriguez,et al.  Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. , 2000, The New England journal of medicine.

[104]  K Cameron,et al.  Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Rivest,et al.  What is a safe vaccine? , 2000, Vaccine.

[106]  A. Osterhaus,et al.  Antigenic Drift in the Influenza A Virus (H3N2) Nucleoprotein and Escape from Recognition by Cytotoxic T Lymphocytes , 2000, Journal of Virology.

[107]  B. Murphy,et al.  Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy , 2000, Journal of Virology.

[108]  H. Jin,et al.  Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. , 2000, Virology.

[109]  R. Webster,et al.  Characterization of the Influenza A Virus Gene Pool in Avian Species in Southern China: Was H6N1 a Derivative or a Precursor of H5N1? , 2000, Journal of Virology.

[110]  B. Murphy,et al.  Replacement of the Ectodomains of the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Recombinant Parainfluenza Virus Type 3 (PIV3) with Their Counterparts from PIV2 Yields Attenuated PIV2 Vaccine Candidates , 2000, Journal of Virology.

[111]  G. Gray,et al.  The Naval Health Research Center Respiratory Disease Laboratory. , 2000, Military medicine.

[112]  J. V. van Krieken,et al.  Experimental rhinovirus 16 infection increases intercellular adhesion molecule‐1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[113]  J. McKimm-Breschkin,et al.  Resistance of influenza viruses to neuraminidase inhibitors--a review. , 2000, Antiviral research.

[114]  B. Gibson,et al.  Non‐typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor , 2000, Molecular microbiology.

[115]  S. Madhi,et al.  Increased burden of respiratory viral associated severe lower respiratory tract infections in children infected with human immunodeficiency virus type-1. , 2000, The Journal of pediatrics.

[116]  J. Taubenberger,et al.  Characterization of the 1918 "Spanish" influenza virus neuraminidase gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[117]  L. Andréoletti,et al.  Differential detection of rhinoviruses and enteroviruses RNA sequences associated with classical immunofluorescence assay detection of respiratory virus antigens in nasopharyngeal swabs from infants with bronchiolitis , 2000, Journal of medical virology.

[118]  T. Nguyen,et al.  Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides. , 2000, Vaccine.

[119]  Y. Guan,et al.  Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. , 2000, Veterinary microbiology.

[120]  P. Thuras,et al.  Prenatal viral infection causes alterations in nNOS expression in developing mouse brains , 2000, Neuroreport.

[121]  M. Horwitz,et al.  An Adenovirus Inhibitor of Tumor Necrosis Factor Alpha-Induced Apoptosis Complexes with Dynein and a Small GTPase , 2000, Journal of Virology.

[122]  A Villringer,et al.  fMRI shows multiple somatotopic digit representations in human primary somatosensory cortex , 2000, Neuroreport.

[123]  J. Kimpen,et al.  Therapy for respiratory tract infections caused by respiratory syncytial virus , 2000, European Journal of Pediatrics.

[124]  T. Seemungal,et al.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[125]  N. Papadopoulos,et al.  Rhinovirus infection induces major histocompatibility complex class I and costimulatory molecule upregulation on respiratory epithelial cells. , 2000, The Journal of infectious diseases.

[126]  R. Webster,et al.  Current Research on Influenza and other Respiratory Viruses: II International Symposium , 2000, Antiviral Research.

[127]  D. Moskophidis,et al.  The Role of Alpha/Beta and Gamma Interferons in Development of Immunity to Influenza A Virus in Mice , 2000, Journal of Virology.

[128]  M. R. Howell,et al.  Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits. , 2000, The American journal of tropical medicine and hygiene.

[129]  R. Bethell,et al.  Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir. , 2000, Analytical biochemistry.

[130]  B. Kjellman,et al.  Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. , 2000, American journal of respiratory and critical care medicine.

[131]  J. Bonnefoy,et al.  CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment , 2000, Journal of Virology.

[132]  A. García-Sastre,et al.  Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[133]  B. Murphy,et al.  A Recombinant Human Parainfluenza Virus Type 3 (PIV3) in Which the Nucleocapsid N Protein Has Been Replaced by That of Bovine PIV3 Is Attenuated in Primates , 2000, Journal of Virology.

[134]  D. Noyola,et al.  Effect of rapid diagnosis on management of influenza A infections , 2000, The Pediatric infectious disease journal.

[135]  E. Connor,et al.  Prophylaxis against respiratory syncytial virus in premature infants , 2000, The Lancet.

[136]  A. Tamanini,et al.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.

[137]  I. M. Gonzalez,et al.  Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. , 2000, Vaccine.

[138]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[139]  K. Henrickson,et al.  DETECTION OF RESPIRATORY VIRUSES IN THE MIDDLE EAR FLUIDS OF CHILDREN WITH ACUTE OTITIS MEDIA BY MULTIPLEX REVERSE TRANSCRIPTION: POLYMERASE CHAIN REACTION ASSAY , 2000, The Pediatric Infectious Disease Journal.

[140]  S. Cryz,et al.  Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant. , 2000, The Journal of infectious diseases.

[141]  John J. Treanor,et al.  Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza , 2000 .

[142]  Lihan K. Yan,et al.  Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. , 2000, The Journal of pediatrics.

[143]  J. Hendley,et al.  Nose blowing propels nasal fluid into the paranasal sinuses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[144]  H. Granzow,et al.  Chimeric Bovine Respiratory Syncytial Virus with Glycoprotein Gene Substitutions from Human Respiratory Syncytial Virus (HRSV): Effects on Host Range and Evaluation as a Live-Attenuated HRSV Vaccine , 2000, Journal of Virology.

[145]  R. Couch,et al.  Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.

[146]  T. Jefferson,et al.  Prevention and early treatment of influenza in healthy adults. , 2000, Vaccine.

[147]  A. Kidd,et al.  Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor , 2000, Journal of Virology.

[148]  H. Jin,et al.  Respiratory Syncytial Virus That Lacks Open Reading Frame 2 of the M2 Gene (M2-2) Has Altered Growth Characteristics and Is Attenuated in Rodents , 2000, Journal of Virology.

[149]  R. Betts,et al.  Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. , 1999, Vaccine.

[150]  S. Gravenstein,et al.  Mortality Following Isolation of Various Respiratory Viruses in Nursing Home Residents , 1999, Infection Control & Hospital Epidemiology.

[151]  J. Mills,et al.  Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity. , 1999, The Journal of infectious diseases.

[152]  M. St. Claire,et al.  Replacement of the F and G Proteins of Respiratory Syncytial Virus (RSV) Subgroup A with Those of Subgroup B Generates Chimeric Live Attenuated RSV Subgroup B Vaccine Candidates , 1999, Journal of Virology.

[153]  M. Bewley,et al.  Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. , 1999, Science.

[154]  I. Kovesdi,et al.  Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. , 1999, Science.

[155]  Anna Mitraki,et al.  A triple β-spiral in the adenovirus fibre shaft reveals a new structural motif for a fibrous protein , 1999, Nature.

[156]  S. Johnston,et al.  Respiratory Epithelial Cell Expression of Vascular Cell Adhesion Molecule-1 and Its Up-regulation by Rhinovirus Infection via NF-κB and GATA Transcription Factors* , 1999, The Journal of Biological Chemistry.

[157]  M. Koch,et al.  The neurobiology of startle , 1999, Progress in Neurobiology.

[158]  E. Wang,et al.  Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada. , 1999, The Pediatric infectious disease journal.

[159]  H. Maassab,et al.  The development of live attenuated cold‐adapted influenza virus vaccine for humans , 1999, Reviews in medical virology.

[160]  A. Takada,et al.  Avirulent Avian Influenza Virus as a Vaccine Strain against a Potential Human Pandemic , 1999, Journal of Virology.

[161]  D. Matthews,et al.  In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease , 1999, Antimicrobial Agents and Chemotherapy.

[162]  A. Bermingham,et al.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[163]  D. Matthews,et al.  Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[164]  D. Perera,et al.  Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak , 1999, The Lancet.

[165]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[166]  E. Simões.  Respiratory syncytial virus infection , 1999, The Lancet.

[167]  S. Gravenstein,et al.  Non‐Influenza Respiratory Viruses May Overlap and Obscure Influenza Activity , 1999, Journal of the American Geriatrics Society.

[168]  S. Blomqvist,et al.  Rapid Detection of Human Rhinoviruses in Nasopharyngeal Aspirates by a Microwell Reverse Transcription-PCR–Hybridization Assay , 1999, Journal of Clinical Microbiology.

[169]  M. Meltzer,et al.  The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.

[170]  J. Crowe,et al.  RhoA Interacts with the Fusion Glycoprotein of Respiratory Syncytial Virus and Facilitates Virus-Induced Syncytium Formation , 1999, Journal of Virology.

[171]  J. Towbin,et al.  The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease. , 1999, Journal of the American College of Cardiology.

[172]  B. Barlogie,et al.  Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy , 1999, Bone Marrow Transplantation.

[173]  N. Cox,et al.  Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. , 1999, Virology.

[174]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[175]  Y. Guan,et al.  Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[176]  W. Wold,et al.  Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.

[177]  K. Shortridge.  Poultry and the influenza H5N1 outbreak in Hong Kong, 1997: abridged chronology and virus isolation. , 1999, Vaccine.

[178]  K. Nichol.  The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. , 1999, Vaccine.

[179]  K. Nichol.  Complications of influenza and benefits of vaccination. , 1999, Vaccine.

[180]  J. Wittes,et al.  Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. , 1999, JAMA.

[181]  J. Petitjean,et al.  Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children , 1999, Journal of Clinical Virology.

[182]  R. Webster,et al.  First International Symposium on Influenza and Other Respiratory Viruses: summary and overview , 1999, Antiviral Research.

[183]  J. Bonnefoy,et al.  Identification of Multiple Protective Epitopes (Protectopes) in the Central Conserved Domain of a Prototype Human Respiratory Syncytial Virus G Protein , 1999, Journal of Virology.

[184]  R. Karron,et al.  Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. , 1999, The Journal of infectious diseases.

[185]  M. Sears,et al.  Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[186]  G. Kearns,et al.  Single Oral Dose Escalation Pharmacokinetics of Pleconaril (VP 63843) Capsules in Adults , 1999, Journal of clinical pharmacology.

[187]  M. Schroth,et al.  Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. , 1999, American journal of respiratory cell and molecular biology.

[188]  T. Nguyen,et al.  Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: influence of adjuvants and maternal antibodies. , 1999, The Journal of infectious diseases.

[189]  T. Nguyen,et al.  Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment. , 1999, Virology.

[190]  F. Hayden,et al.  Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. , 1999, JAMA.

[191]  N. Papadopoulos,et al.  Rhinoviruses replicate effectively at lower airway temperatures , 1999, Journal of medical virology.

[192]  J. Yewdell,et al.  Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression. , 1999, Journal of immunology.

[193]  K. Subbarao,et al.  Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. , 1999, The Journal of infectious diseases.

[194]  S. Johnston,et al.  Rhinovirus Infection Induces Expression of Its Own Receptor Intercellular Adhesion Molecule 1 (ICAM-1) via Increased NF-κB-mediated Transcription* , 1999, The Journal of Biological Chemistry.

[195]  K. Shortridge.  The 1918 'Spanish' flu: pearls from swine? , 1999, Nature Medicine.

[196]  D. Burton,et al.  Human Antibody Responses to Mature and Immature Forms of Viral Envelope in Respiratory Syncytial Virus Infection: Significance for Subunit Vaccines , 1999, Journal of Virology.

[197]  M. St. Claire,et al.  Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees , 1999, Journal of Virology.

[198]  D. Matthews,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. , 1999, Journal of medicinal chemistry.

[199]  D. Matthews,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. , 1999, Journal of medicinal chemistry.

[200]  J. Towbin,et al.  Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. , 1999, Circulation.

[201]  K. Nichol,et al.  Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease , 1999, Annals of Internal Medicine.

[202]  B. Murphy,et al.  Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[203]  F. Hayden,et al.  Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. , 1999, American journal of respiratory and critical care medicine.

[204]  G. Kearns,et al.  Single-Dose Pharmacokinetics of a Pleconaril (VP63843) Oral Solution in Children and Adolescents , 1999, Antimicrobial Agents and Chemotherapy.

[205]  T. Pokka,et al.  Time to development of acute otitis media during an upper respiratory tract infection in children. , 1999, The Pediatric infectious disease journal.

[206]  J. Taubenberger,et al.  Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[207]  D. Wallach,et al.  Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis , 1999 .

[208]  P. Collins,et al.  Identification of Mutations Contributing to the Temperature-Sensitive, Cold-Adapted, and Attenuation Phenotypes of the Live-Attenuated Cold-Passage 45 (cp45) Human Parainfluenza Virus 3 Candidate Vaccine , 1999, Journal of Virology.

[209]  F. Carrat,et al.  Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[210]  R. Elton,et al.  Infection with respiratory syncytial virus enhances expression of native receptors for non-pilate Neisseria meningitidis on HEp-2 cells. , 1999, FEMS immunology and medical microbiology.

[211]  T. Heikkinen,et al.  Prevalence of various respiratory viruses in the middle ear during acute otitis media. , 1999, The New England journal of medicine.

[212]  L. Bakaletz,et al.  Fimbria-Mediated Enhanced Attachment of NontypeableHaemophilus influenzae to Respiratory Syncytial Virus-Infected Respiratory Epithelial Cells , 1999, Infection and Immunity.

[213]  D. Levy,et al.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. , 1998, Virology.

[214]  O'donnell,et al.  Anaphylactic sensitization to aeroantigen during respiratory virus infection , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[215]  O. Ramilo,et al.  Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. , 1998, The Journal of infectious diseases.

[216]  N. Swerdlow,et al.  Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats , 1998, Psychopharmacology.

[217]  A. Falsey.  Respiratory syncytial virus infection in older persons. , 1998, Vaccine.

[218]  R. Webster,et al.  Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. , 1998, The Journal of infectious diseases.

[219]  G. Kearns,et al.  Single-Dose Pharmacokinetics of a Pleconaril (VP63843) Oral Solution and Effect of Food , 1998, Antimicrobial Agents and Chemotherapy.

[220]  M. Zambon,et al.  Multiplex PCR for Typing and Subtyping Influenza and Respiratory Syncytial Viruses , 1998, Journal of Clinical Microbiology.

[221]  E. Simões,et al.  Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease , 1998 .

[222]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[223]  M. MacDonald,et al.  Huntingtin interacts with a family of WW domain proteins. , 1998, Human molecular genetics.

[224]  F. Hayden,et al.  Detection of Rhinovirus, Respiratory Syncytial Virus, and Coronavirus Infections in Acute Otitis Media by Reverse Transcriptase Polymerase Chain Reaction , 1998, Pediatrics.

[225]  D. Matthews,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. , 1998, Journal of medicinal chemistry.

[226]  J. McKimm-Breschkin,et al.  The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en. , 1998, Virology.

[227]  J. Fan,et al.  Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex). , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[228]  F. Hayden,et al.  The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.

[229]  J. Sprent,et al.  Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. , 1998, Immunity.

[230]  M. R. Howell,et al.  Prevention of adenoviral acute respiratory disease in Army recruits: cost-effectiveness of a military vaccination policy. , 1998, American journal of preventive medicine.

[231]  E. Mulholland,et al.  Respiratory syncytial virus infection in tropical and developing countries , 1998, Tropical medicine & international health : TM & IH.

[232]  B. O'hara,et al.  CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats. , 1998, Antiviral research.

[233]  Jian Kang,et al.  Interaction of an Adenovirus E3 14.7-Kilodalton Protein with a Novel Tumor Necrosis Factor Alpha-Inducible Cellular Protein Containing Leucine Zipper Domains , 1998, Molecular and Cellular Biology.

[234]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[235]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[236]  E. Walsh,et al.  Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. , 1998, The Journal of infectious diseases.

[237]  N. Cox,et al.  Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.

[238]  J. Bennink,et al.  Mechanism of protective immunity against influenza virus infection in mice without antibodies. , 1998, Journal of immunology.

[239]  F. Hayden,et al.  Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza. , 1997, The Journal of infectious diseases.

[240]  T. Heikkinen,et al.  Role of Viruses in Middle‐ear Disease a , 1997, Annals of the New York Academy of Sciences.

[241]  P. Piedra,et al.  Dual Respiratory Virus Infections , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[242]  F. Hayden,et al.  Frequency and natural history of rhinovirus infections in adults during autumn , 1997, Journal of clinical microbiology.

[243]  H. Druce,et al.  Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[244]  D. Pfarr,et al.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.

[245]  W. Keatinge,et al.  Mortality related to cold weather in elderly people in southeast England, 1979-94 , 1997, BMJ.

[246]  J. Gwaltney,et al.  Effectiveness of clemastine fumarate for treatment of rhinorrhea and sneezing associated with the common cold. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[247]  H. Binz,et al.  Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. , 1997, The Journal of infectious diseases.

[248]  M. V. von Herrath,et al.  Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[249]  P. Tournier,et al.  Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide. , 1997, The Journal of infectious diseases.

[250]  A. Mcclelland,et al.  Surface expression of intercellular adhesion molecule 1 on epithelial cells in the human adenoid. , 1997, The Journal of infectious diseases.

[251]  M. Uhlén,et al.  Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. , 1997, Virology.

[252]  P. Scuderi,et al.  Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. , 1997, American journal of respiratory and critical care medicine.

[253]  A. Osterhaus,et al.  Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. , 1997, The Journal of general virology.

[254]  A. Kajon,et al.  Chronic pulmonary sequelae of adenovirus infection , 1997, Pediatric pulmonology. Supplement.

[255]  MD Estella Whimbey,et al.  Community Respiratory Virus Infections in Immunocompromised Patients with Cancer , 1997, The American Journal of Medicine.

[256]  MD Janet A. Englund,et al.  Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons , 1997, The American Journal of Medicine.

[257]  C. Croce,et al.  A potential role for interleukin-15 in the regulation of human natural killer cell survival. , 1997, The Journal of clinical investigation.

[258]  Y. Li,et al.  Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers , 1997, Journal of virology.

[259]  E. D. de KLERK,et al.  Effect of experimental rhinovirus 16 colds on airway hyperresponsiveness to histamine and interleukin‐8 in nasal lavage in asthmatic subjects in vivo , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[260]  J. Gwaltney,et al.  Incubation periods of experimental rhinovirus infection and illness. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[261]  S. Crawford,et al.  Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation , 1996, Antimicrobial agents and chemotherapy.

[262]  R. Karron,et al.  Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in two- to six-month-old infants. , 1996, The Pediatric infectious disease journal.

[263]  G. Wadell,et al.  Molecular epidemiology of adenovirus types 3 and 7 isolated from children with pneumonia in Beijing , 1996, Journal of medical virology.

[264]  J. Englund,et al.  Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults , 1996, Journal of clinical microbiology.

[265]  R. Turner,et al.  Randomized controlled trial of clemastine fumarate for treatment of experimental rhinovirus colds. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[266]  R. Tripp,et al.  The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model , 1996, Journal of virology.

[267]  R. Sherertz,et al.  A Cloud Adult: The Staphylococcus aureus-Virus Interaction Revisited , 1996, Annals of Internal Medicine.

[268]  J. Lenard.  Negative-strand virus M and retrovirus MA proteins: all in a family? , 1996, Virology.

[269]  G. Wadell,et al.  Sequence analysis of the E3 region and fiber gene of human adenovirus genome type 7h. , 1996, Virology.

[270]  R. Chanock,et al.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[271]  R. Karron,et al.  A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. , 1995, The Journal of infectious diseases.

[272]  E. Tuomanen,et al.  The molecular basis of pneumococcal infection: a hypothesis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[273]  K. Nichol,et al.  The effectiveness of vaccination against influenza in healthy, working adults. , 1995, The New England journal of medicine.

[274]  E. Walter,et al.  Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. , 1995, Archives of Pediatrics & Adolescent Medicine.

[275]  A. Falsey,et al.  Respiratory syncytial virus and influenza A infections in the hospitalized elderly. , 1995, The Journal of infectious diseases.

[276]  S. Efrat,et al.  Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[277]  C. Rouzioux,et al.  Molecular identification of viruses in sudden infant death associated with myocarditis and pericarditis. , 1995, The Pediatric infectious disease journal.

[278]  Stephen T Holgate,et al.  Community study of role of viral infections in exacerbations of asthma in 9-11 year old children , 1995, BMJ.

[279]  S. Johnston,et al.  Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. , 1995, American journal of respiratory and critical care medicine.

[280]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[281]  T. Heikkinen,et al.  Viral-bacterial interaction in acute otitis media. , 1994, The Pediatric infectious disease journal.

[282]  G. Wadell,et al.  Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period , 1994, Journal of clinical microbiology.

[283]  T. Heikkinen,et al.  Temporal development of acute otitis media during upper respiratory tract infection. , 1994, The Pediatric infectious disease journal.

[284]  D. Matthews,et al.  Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein , 1994, Cell.

[285]  R. Garofalo,et al.  Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. , 1994, The Journal of infectious diseases.

[286]  R. Baughman,et al.  Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. , 1994, Chest.

[287]  D R Burton,et al.  Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[288]  R D Miller,et al.  Computed tomographic study of the common cold. , 1994, The New England journal of medicine.

[289]  K. Cross,et al.  Respiratory syncytial virus or influenza? , 1993, The Lancet.

[290]  C. Hall,et al.  Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children , 1993 .

[291]  J. Patel,et al.  Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. , 1993, The Journal of infectious diseases.

[292]  R. Couch,et al.  Comparison of rapid diagnostic techniques for respiratory syncytial and influenza A virus respiratory infections in young children , 1993, Journal of clinical microbiology.

[293]  J. Garcia,et al.  Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. , 1993, Virology.

[294]  B. Murphy.  USE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A REASSORTANT VIRUS VACCINES IN INFANTS, CHILDREN, YOUNG ADULTS, AND ELDERLY ADULTS , 1993 .

[295]  B. Murphy,et al.  A cold-adapted mutant of parainfluenza virus type 3 is attenuated and protective in chimpanzees. , 1993, The Journal of infectious diseases.

[296]  J. Gwaltney.  Combined antiviral and antimediator treatment of rhinovirus colds. , 1992, The Journal of infectious diseases.

[297]  E. Wang,et al.  Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. , 1992, The Journal of pediatrics.

[298]  F. Hayden,et al.  Effects of Naproxen on Experimental Rhinovirus Colds , 1992, Annals of Internal Medicine.

[299]  B. Osborne,et al.  An outbreak of respiratory syncytial virus in a bone marrow transplant center. , 1992, The Journal of infectious diseases.

[300]  C. Tinelli,et al.  Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. , 1992, Journal of cardiovascular pharmacology.

[301]  Shortridge Kf.  Pandemic influenza: a zoonosis? , 1992, Seminars in respiratory infections.

[302]  Hayden Fg,et al.  Psychological stress and the common cold. , 1992 .

[303]  T. Chonmaitree,et al.  Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes: a possible role in the mechanism of virus-induced asthma. , 1991, The Journal of infectious diseases.

[304]  C. Cunningham,et al.  Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. , 1991, Pediatrics.

[305]  D. Jones,et al.  Influenza A and meningococcal disease , 1991, The Lancet.

[306]  Andrew P. Smith,et al.  Psychological stress and susceptibility to the common cold. , 1991, The New England journal of medicine.

[307]  F. Hayden,et al.  Acute respiratory viral infections in ambulatory children of urban northeast Brazil. , 1991, The Journal of infectious diseases.

[308]  T. Heikkinen,et al.  Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.

[309]  O. Ruuskanen,et al.  Recurrent wheezy bronchitis and viral respiratory infections. , 1991, Archives of disease in childhood.

[310]  O. Ruuskanen,et al.  Clinical role of respiratory virus infection in acute otitis media , 1990, International Journal of Pediatric Otorhinolaryngology.

[311]  W. Doyle,et al.  Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. , 1990, The Journal of allergy and clinical immunology.

[312]  S. Heidemann,et al.  Does prematurity alter the course of respiratory syncytial virus infection? , 1990, Critical care medicine.

[313]  N. Choudry,et al.  The effect of sulindac on the abnormal cough reflex associated with dry cough. , 1990, The Journal of pharmacology and experimental therapeutics.

[314]  T. Chonmaitree,et al.  Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. , 1990, The Journal of infectious diseases.

[315]  O. Ruuskanen,et al.  Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. , 1990, The Journal of pediatrics.

[316]  J. Hendley,et al.  Respiratory virus infection of monolayer cultures of human nasal epithelial cells. , 1990, The American review of respiratory disease.

[317]  J. Tomassini,et al.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[318]  J. Waner,et al.  Detection of multiple viral agents in nasopharyngeal specimens yielding respiratory syncytial virus (RSV). An assessment of diagnostic strategy and clinical significance. , 1989, Diagnostic microbiology and infectious disease.

[319]  R. Chanock,et al.  Role of early region 3 (E3) in pathogenesis of adenovirus disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[320]  A. Mcclelland,et al.  The major human rhinovirus receptor is ICAM-1 , 1989, Cell.

[321]  O. Ruuskanen,et al.  Acute otitis media and respiratory virus infections. , 1989, The Pediatric infectious disease journal.

[322]  R. W. Miller,et al.  Simultaneous infection with respiratory syncytial virus and other respiratory pathogens. , 1988, American journal of diseases of children.

[323]  K. Gutierrez,et al.  Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. , 1988, Pediatrics.

[324]  R. Chanock,et al.  Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses. , 1988, Virus research.

[325]  F. Hayden,et al.  Modification of experimental rhinovirus colds by receptor blockade. , 1988, Antiviral research.

[326]  H. Waldmann,et al.  Do L3T4+ T cells act as effector cells in protection against influenza virus infection. , 1987, Immunology.

[327]  F. Booy,et al.  Functional reconstitution of influenza virus envelopes. , 1987, The EMBO journal.

[328]  W. S. Jordan,et al.  A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. , 1987, Virology.

[329]  M. Plotkowski,et al.  Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. , 1986, The American review of respiratory disease.

[330]  E. Walsh,et al.  Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection , 1986, Journal of clinical microbiology.

[331]  R. Turner,et al.  Sites of rhinovirus recovery after point inoculation of the upper airway. , 1986, JAMA.

[332]  R. Sherertz,et al.  Outbreak of Staphylococcal Infection in Two Hospital Nurseries Traced to a Single Nasal Carrier , 1986, Infection Control.

[333]  C B Hall,et al.  Respiratory syncytial viral infection in children with compromised immune function. , 1986, The New England journal of medicine.

[334]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[335]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[336]  C. Scholtissek,et al.  The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. , 1985, Virology.

[337]  R. Chanock,et al.  Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. , 1985, Virus research.

[338]  John E. Johnson,et al.  Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.

[339]  R. Chanock,et al.  Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats , 1985, Journal of virology.

[340]  A. Linhares,et al.  Molecular epidemiology of adenoviruses: global distribution of adenovirus 7 genome types , 1985, Journal of clinical microbiology.

[341]  W. P. Glezen,et al.  Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. , 1984, The Journal of infectious diseases.

[342]  C. Hall,et al.  Long-term prospective study in children after respiratory syncytial virus infection. , 1984, The Journal of pediatrics.

[343]  F. Hayden,et al.  Intranasal Interferon-α2, Treatment of Experimental Rhinoviral Colds , 1984 .

[344]  D. Snydman,et al.  A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery. , 1984, The Journal of pediatrics.

[345]  G. M. Stokes,et al.  Respiratory problems 2 years after acute bronchiolitis in infancy. , 1983, Archives of disease in childhood.

[346]  A. McMichael,et al.  Cytotoxic T-cell immunity to influenza. , 1983, The New England journal of medicine.

[347]  J. C. Bell,et al.  Influenza vaccination. , 1983, JAMA.

[348]  K. Shortridge,et al.  AN INFLUENZA EPICENTRE? , 1982, The Lancet.

[349]  C. Hall,et al.  Respiratory syncytial viral infection in infants with congenital heart disease. , 1982, The New England journal of medicine.

[350]  A. M. Collier,et al.  A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. , 1982, The New England journal of medicine.

[351]  F. Hayden,et al.  Prophylactic activity of intranasal enviroxime against experimentally induced rhinovirus type 39 infection , 1982, Antimicrobial Agents and Chemotherapy.

[352]  C. Ellenbogen.  The common cold. , 1981, American family physician.

[353]  A. Frank,et al.  Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. , 1981, The Journal of pediatrics.

[354]  J. Hendley,et al.  Rhinovirus Inactivation by Aqueous Iodine in Vitro and on Skin , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[355]  Carter Ch,et al.  Rhinovirus inactivation by aqueous iodine in vitro and on skin. , 1980 .

[356]  I. Berzins,et al.  Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas , 1980, Infection and immunity.

[357]  M. Potier,et al.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. , 1979, Analytical biochemistry.

[358]  R. Chanock,et al.  Influenza A and B virus infection in infants and young children during the years 1957-1976. , 1979, American journal of epidemiology.

[359]  A. J. Martin,et al.  EPIDEMIOLOGY OF RESPIRATORY VIRAL INFECTION AMONG PÆDIATRIC INPATIENTS OVER A SIX-YEAR PERIOD IN NORTH-EAST ENGLAND , 1978, The Lancet.

[360]  J. Hendley,et al.  Evaluation of Virucidal Compounds for Inactivation of Rhinovirus on Hands , 1978, Antimicrobial Agents and Chemotherapy.

[361]  J. Hendley,et al.  Hand-to-hand transmission of rhinovirus colds. , 1978, Annals of internal medicine.

[362]  Lowe Ja,et al.  Need we revive falling autopsy rates? Time trends in PAS hospitals in the United States. , 1977 .

[363]  J. Paradise.  On tympanostomy tubes: rationale, results, reservations, and recommendations. , 1977, Pediatrics.

[364]  P. Gardner,et al.  Respiratory syncytial virus infection in north-east England. , 1976, British medical journal.

[365]  K. Mcintosh.  Bronchiolitis and asthma: Possible common pathogenetic pathways☆ , 1976, Journal of Allergy and Clinical Immunology.

[366]  R. Chanock,et al.  Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. , 1973, American journal of epidemiology.

[367]  R. Wenzel,et al.  Transmission of rhinovirus colds by self-inoculation. , 1973, The New England journal of medicine.

[368]  J. Hendley,et al.  Relation between naturally acquired immunity and infectivity of two rhinoviruses in volunteers. , 1972, The Journal of infectious diseases.

[369]  R. Chanock,et al.  Infections in 18,000 infants and children in a controlled study of respiratory tract disease. II. Variation in adenovirus infections by year and season. , 1972, American journal of epidemiology.

[370]  R. Chanock,et al.  Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. , 1971, Pediatrics.

[371]  W. Marine,et al.  Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. , 1971, Archives of internal medicine.

[372]  C. A. Phillips,et al.  A collaborative report: rhinoviruses--extension of the numbering system. , 1971, Virology.

[373]  J. M. Gwaltney,et al.  Rhinovirus Inhibition by 3-Substituted Triazinoindoles , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[374]  Douglas Rg,et al.  Attenuation of Rhinovirus Type 15 for Humans , 1969 .

[375]  R. Chanock,et al.  Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. , 1969, American journal of epidemiology.

[376]  J. Steen-johnsen,et al.  SEVERE ILLNESSES DUE TO ADENOVIRUS TYPE 7 IN CHILDREN , 1969, Acta paediatrica Scandinavica.

[377]  H. Maassab,et al.  Biologic and immunologic characteristics of cold-adapted influenza virus. , 1969, Journal of immunology.

[378]  W. S. Jordan,et al.  Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. , 1969, American journal of epidemiology.

[379]  R. Chanock,et al.  Low-temperature-grown RS virus in adult volunteers. , 1968, JAMA.

[380]  Edwin H. Lennette,et al.  Rhinoviruses , 1968 .

[381]  W. S. Jordan,et al.  Rhinovirus infections in an industrial population. II. Characteristics of illness and antibody response. , 1967, JAMA.

[382]  D. Becroft.  Histopathology of fatal adenovirus infection of the respiratory tract in young children , 1967, Journal of clinical pathology.

[383]  B. Berglund,et al.  The role of respiratory syncytial virus in otitis media in children. , 1967, Acta oto-laryngologica.

[384]  W. S. Jordan,et al.  Rhinovirus infections in an industrial population. I. The occurrence of illness. , 1966, The New England journal of medicine.

[385]  P. Toivanen,et al.  Isolation of respiratory syncytial virus from middle ear exudates of infants. , 1966, Archives of disease in childhood.

[386]  R. Douglas,et al.  The role of nasal secretion and serum antibody in the rhinovirus common cold. , 1966, American journal of epidemiology.

[387]  J. M. Gwaltney,et al.  Micro-Neutralization Test for Identification of Rhinovirus Serotypes.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[388]  D. Hamre,et al.  Virologic studies of acute respiratory disease in young adults. IV. Virus isolations during four years of surveillance. , 1966, American journal of epidemiology.

[389]  B. Hanes,et al.  Multiple respiratory virus infections in hospitalized children. , 1965, American journal of epidemiology.

[390]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[391]  H. Eichenwald,et al.  The "cloud baby": an example of bacterial-viral interaction. , 1960, American journal of diseases of children.

[392]  R. Chanock,et al.  Newly recognized myxoviruses from children with respiratory disease. , 1958, The New England journal of medicine.

[393]  R. Chanock,et al.  Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. , 1957, American journal of hygiene.

[394]  W. Mogabgab,et al.  A Cytopathogenic Agent Isolated from Naval Recruits with Mild Respiratory Illnesses.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[395]  C. Yoshie.  On the isolation of influenza virus from mid-ear discharge of influenza otitis media. , 1955, Japanese journal of medical science & biology.

[396]  M. R. Hllleman,et al.  Recovery of New Agent from Patients with Acute Respiratory Illness , 1954, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[397]  R. Huebner,et al.  Isolation of a Cytopathogenic Agent from Human Adenoids Undergoing Spontaneous Degeneration in Tissue Culture , 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[398]  A. Proetz,et al.  Applied Physiology of the Nose , 1942 .

[399]  J. Oxford,et al.  Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine. , 2002, The Journal of infectious diseases.

[400]  E. Emamian,et al.  Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice , 2002, Molecular Psychiatry.

[401]  R. Webster,et al.  Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. , 2002, Antiviral research.

[402]  K. Sepkowitz,et al.  Respiratory syncytial virus infection following hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[403]  Y. Guan,et al.  H5N1 virus: beaten but is it vanquished? Emergence and control of zoonotic ortho- and paramyxovirus diseases , 2001 .

[404]  D. Nokes,et al.  Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. , 2001, Bulletin of the World Health Organization.

[405]  S. Fatemi,et al.  Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression , 2000, Molecular Psychiatry.

[406]  Joan Wilson,et al.  Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[407]  J. Crowe,et al.  A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3 , 2000, Nature Medicine.

[408]  Jiahuai Han,et al.  The p38 signal transduction pathway: activation and function. , 2000, Cellular signalling.

[409]  R. Hirsch,et al.  Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation – a compassionate use experience , 2000, Bone Marrow Transplantation.

[410]  M Tisdale,et al.  Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors , 2000, Reviews in medical virology.

[411]  E. Walsh,et al.  Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[412]  G. Kearns,et al.  Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network. , 1999, Antimicrobial agents and chemotherapy.

[413]  R. E. Whalen,et al.  Animal models of human emotion and cognition , 1999 .

[414]  J. Crowe.  Host responses to respiratory virus infection and immunization. , 1999, Current topics in microbiology and immunology.

[415]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[416]  K. Tsai,et al.  Hepatitis A vaccine in healthy adults: a comparison of immunogenicity and reactogenicity between two- and three-dose regimens. , 1999, Vaccine.

[417]  A. Podda,et al.  Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. , 1999, Vaccine.

[418]  R. Chanock,et al.  Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. , 1999, Advances in virus research.

[419]  N. Cox.  Prevention and control of influenza. , 1999, Lancet.

[420]  D. Matthews,et al.  Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. , 1998, Journal of medicinal chemistry.

[421]  M A Geyer,et al.  Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.

[422]  J L Nielsen,et al.  [Influenza vaccination]. , 1997, Ugeskrift for laeger.

[423]  R. Holman,et al.  Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. , 1996, Emerging infectious diseases.

[424]  S. Holgate,et al.  Lower airways inflammatory response during rhinovirus colds. , 1995, International Archives of Allergy and Immunology.

[425]  J. Englund,et al.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. , 1995, Bone marrow transplantation.

[426]  R. Chanock,et al.  Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. , 1994, Vaccine.

[427]  K. Shortridge.  Pandemic influenza: a zoonosis? , 1992, Seminars in respiratory infections.

[428]  A. McMichael.  Cytotoxic T lymphocytes: specificity, surveillance, and escape. , 1992, Advances in cancer research.

[429]  S. Sharma,et al.  Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. , 1992, International journal of pediatric otorhinolaryngology.

[430]  C. Marchant,et al.  Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". , 1992, The Journal of pediatrics.

[431]  M. S. Parker,et al.  Prevention and control of influenza recommendations of the Immunization Practices Advisory Committee (ACIP). , 1991, MMWR Recommendations and Reports.

[432]  A. Hornsleth,et al.  Sensitive enzyme immunoassay for the rapid diagnosis of influenza A virus infections in clinical specimens. , 1990, Research in virology.

[433]  J. Hendley,et al.  Mechanisms of transmission of rhinovirus infections. , 1988, Epidemiologic reviews.

[434]  John E. Johnson,et al.  The Structure of a Human Common Cold Virus (Rhinovirus 14) and its Functional Relations to Other Picornaviruses , 1987 .

[435]  R. Turner,et al.  Symposium on rhinovirus pathogenesis: introduction. , 1984, Acta oto-laryngologica. Supplementum.

[436]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.

[437]  R. Belshe,et al.  Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers , 1982, Journal of medical virology.

[438]  L. Stanberry,et al.  Preface to the fifth edition , 2014 .

[439]  R. Douglas,et al.  Attenuation of Rhinovirus Type 15 for Humans , 1969, Nature.

[440]  W. S. Jordan,et al.  Rhinovirus infections in an industrial population. 3. Number and prevalence of serotypes. , 1968, American journal of epidemiology.

[441]  Rhinoviruses: a numbering system. , 1967, Nature.

[442]  William S. Jordan,et al.  Illness in the home : a study of 25,000 illnesses in a group of Cleveland families , 1964 .

[443]  R. Chanock,et al.  Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[444]  W. H. Frost,et al.  The Incidence and Time Distribution of Common Colds in Several Groups kept under Continuous Observation. , 1932 .